Skip to main content
. 2022 Aug 30;13:940406. doi: 10.3389/fphar.2022.940406

FIGURE 1.

FIGURE 1

Resveratrol (RES) and fibroblast growth factor 1 (FGF1) co-treatment alleviated liver damage, inflammation, and hepatocyte apoptosis in doxorubicin (DOX)-treated mice. (A) Effects of RES and/or FGF1 on the liver index in mice with DOX-induced liver damage (n = 6). (B,C) Serum levels of ALT and AST after the indicated treatments (n = 6). (D) Representative light microscopy images showing histopathological changes in liver tissues stained with H&E staining. (E,F) Representative microscopy images showing IHC staining of TNF-α in liver tissues (n = 6). (G–I) Relative mRNA expression levels of Tnfa, Il1b, and Il6 in hepatocytes (n = 6). (J) Representative fluorescence microscopy images of apoptotic hepatocytes labeled by TUNEL staining. Data are expressed as mean ± SD. *p < 0.05.